DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
INDIUM IN 111 SATUMOMAB PENDETIDE
Search structure
Synonyms:
B72.3
CYT-099
CYT-103
CYT-103 (111IN)
CYT-103 111 IN
IN-111 CYT-103
INDIUM (111IN) SATUMOMAB PENDETIDE
INDIUM IN 111 CYT-103
INDIUM IN-111 SATUMOMAB PENDETIDE
MONAB B72.3-GYK-DTPA-111IN
ONCOSCINT
SATUMOMAB
SATUMOMAB PENDETIDE
SATUMOMAB PENDETIDE 111IN
SATUMOMAB PENDETIDE INDIUM IN-111
Status:
Approved (1991)
Entry Type:
Antibody
Cross References
Resources
Reference
ChEMBL
CHEMBL1743091
CONTENTS
Structure
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70
